Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up

Edwards Lifesciences Corporation (EW) reported adjusted earnings per share (EPS) of 66 cents in first-quarter 2024, surpassing the Zacks Consensus Estimate by 3.1%. The figure also increased 6.5% from the year-ago quarter’s level.The quarter’s one-time adjustments primarily include certain litigation expenses and amortization of intangible assets, among others.GAAP EPS were 58 cents in the quarter, up 3.6% year over year.Sales DetailsFirst-quarter net sales were $1.59 billion, up 9.5% year over year on a re ...